Product Information
CHLORHEXIDINE 4% LIQUID is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0178 per ML under NDC 16571011148. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Jul 22, 1986.
Strength
40 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
16571011148
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CHLORHEXIDINE GLUCONATEApproval Type
New Drug (NDA)
FDA Application
NDA019258FDA Approved
7/22/1986
On Market Since
7/26/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORHEXIDINE 4% LIQUID has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0178 per ML |
|---|---|
| All-time high | $0.0250 (Dec 11, 2024) |
| All-time low | $0.0174 (Jan 21, 2026) |
| 52-week high | $0.0197 |
| 52-week low | $0.0174 |
| Median price | $0.0224 |
| Average price | $0.0214 |
| Largest weekly change | -9.1% (Sep 17, 2025) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
chlorhexidine gluconate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORHEXIDINE 4% LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for CHLORHEXIDINE 4% LIQUID, manufactured by Rising Pharma Holdings Inc., is $0.0178 per ML (NDC 16571011148), effective Sep 30, 2026.
How has the price of CHLORHEXIDINE 4% LIQUID changed over time?
Over the history we have for it, the NADAC for CHLORHEXIDINE 4% LIQUID has declined 24.7%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for CHLORHEXIDINE 4% LIQUID?
Since Dec 13, 2023, the NADAC for CHLORHEXIDINE 4% LIQUID has ranged from a low of $0.0174 (Jan 21, 2026) to a high of $0.0250 (Dec 11, 2024), with a median of $0.0224 per ML.
Are there cheaper alternatives to CHLORHEXIDINE 4% LIQUID?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHLORHEXIDINE 4% LIQUID in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORHEXIDINE 4% LIQUID?
CHLORHEXIDINE 4% LIQUID (NDC 16571011148) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.